Ronglin Xie

1.3k citations
31 papers · 1.0k indexed · h-index 18
Topics
Epigenetics and DNA Methylation (6 papers)Genomics and Chromatin Dynamics (6 papers)CAR-T cell therapy research (4 papers)
Partner nations
United StatesChinaChile

In The Last Decade

Ronglin Xie

29 papers receiving 1.0k citations

Peers

Ronglin Xie
Comparison fields: 5 of 81
  • Molecular Biology 754
  • Oncology 264
  • Cancer Research 183
  • Immunology 108
  • Genetics 101
Replace Lenka Kubiczková with:
Lenka Kubiczková Czechia
Lenka Sedlaříková Czechia
Euan W. Baxter United Kingdom
Guoyu Yu United States
Lisa Fusetti Italy
Emanuela Chiarella Italy
Margaret R. Hough Canada
Cailin E. Joyce United States
Ninib Baryawno Sweden
Jenkins United Kingdom
Ronglin Xie relative to Lenka Kubiczková Czechia Lenka Kubiczková's profile →
Citations per field
00.5×2.9×
Lenka Kubiczková · 1×
Citations per year

Countries citing papers authored by Ronglin Xie

Since Specialization
Citations

This map shows the geographic impact of Ronglin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronglin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronglin Xie more than expected).

Fields of papers citing papers by Ronglin Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronglin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronglin Xie. The network helps show where Ronglin Xie may publish in the future.

Co-authorship network of co-authors of Ronglin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ronglin Xie. A scholar is included among the top collaborators of Ronglin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronglin Xie. Ronglin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 62
4 13
5 100
6 30
7 30
8 79
9 67
10 191
11 13
12 86
13 32
14 33
15 31
16 27
17 38
18 3
19 2
20 6

About Ronglin Xie

Ronglin Xie is a scholar working on Immunology and Allergy, Cancer Research and Oncology, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Cancer Research (183 citations), Molecular Biology (754 citations) and Oncology (264 citations). Ronglin Xie has collaborated with scholars based in United States, China and Chile. Frequent co-authors include André J. van Wijnen, Janet L. Stein, George L. Long, Jane B. Lian, Gary S. Stein, Sayyed K. Zaidi, Amjad Javed, Martı́n Montecino, Mohammad Q. Hassan and Stephen N. Jones. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026